Financials Supermax Corporation

Equities

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 29/04/2024 am IST			5-day change	1st Jan Change
0.86 ^MYR	+4.24%		+6.17%	-8.51%

23/04	Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023.	CI
20/02	Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	2,182	10,401	8,638	2,332	2,061	2,211	-	-
Enterprise Value (EV) ¹	2,400	9,548	5,121	-467.4	18.07	2,211	2,211	2,211
P/E ratio	17.7 x	19.9 x	2.25 x	3.16 x	-14.1 x	86 x	46.5 x	21.5 x
Yield	0.9%	-	9.64%	12.6%	4.38%	0.54%	1.07%	1.77%
Capitalization / Revenue	1.47 x	4.88 x	1.21 x	0.87 x	2.51 x	2.14 x	1.72 x	1.52 x
EV / Revenue	1.47 x	4.88 x	1.21 x	0.87 x	2.51 x	2.14 x	1.72 x	1.52 x
EV / EBITDA	9.46 x	13.6 x	1.71 x	2.03 x	-19.8 x	22 x	11.5 x	8.11 x
EV / FCF	19.4 x	9.41 x	2.71 x	-28 x	-2.92 x	-8.84 x	-105 x	79 x
FCF Yield	5.16%	10.6%	36.9%	-3.58%	-34.2%	-11.3%	-0.95%	1.27%
Price to Book	2.01 x	6.51 x	1.8 x	0.48 x	0.45 x	0.5 x	0.5 x	0.49 x
Nbr of stocks (in thousands)	26,12,995	26,00,243	26,17,639	26,64,861	25,76,120	25,70,609	-	-
Reference price ²	0.8350	4.000	3.300	0.8750	0.8000	0.8600	0.8600	0.8600
Announcement Date	30/08/19	10/08/20	26/08/21	22/08/22	29/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	1,489	2,132	7,164	2,687	821.9	1,031	1,287	1,454
EBITDA ¹	230.6	763.6	5,061	1,150	-104	100.6	192.7	272.4
EBIT ¹	186.9	687.5	4,993	1,087	-190.3	-23.47	58.29	131.8
Operating Margin	12.55%	32.25%	69.69%	40.47%	-23.15%	-2.28%	4.53%	9.06%
Earnings before Tax (EBT) ¹	172.6	688.6	5,019	1,070	-196.7	-9.1	52.5	134
Net income ¹	123.8	525.6	3,813	732.4	-149.4	-4.867	44.23	106.8
Net margin	8.31%	24.65%	53.22%	27.26%	-18.18%	-0.47%	3.44%	7.34%
EPS ²	0.0472	0.2011	1.469	0.2770	-0.0567	0.0100	0.0185	0.0400
Free Cash Flow ¹	112.5	1,105	3,185	-83.39	-705.6	-250	-21	28
FCF margin	7.55%	51.83%	44.46%	-3.1%	-85.86%	-24.25%	-1.63%	1.93%
FCF Conversion (EBITDA)	48.8%	144.68%	62.92%	-	-	-	-	10.28%
FCF Conversion (Net income)	90.92%	210.21%	83.53%	-	-	-	-	26.23%
Dividend per Share ²	0.007500	-	0.3180	0.1100	0.0350	0.004670	0.009170	0.0152
Announcement Date	30/08/19	10/08/20	26/08/21	22/08/22	29/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: June	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt	218	-	-	-	-	-	-	-
Net Cash position	-	853	3,517	2,799	2,043	-	-	-
Leverage (Debt/EBITDA)	0.946 x	-	-	-	-	-	-	-
Free Cash Flow ¹	113	1,105	3,185	-83.4	-706	-250	-21	28
ROE (net income / shareholders' equity)	10.5%	38.8%	121%	15.3%	-3.17%	0.08%	1.47%	2.31%
ROA (Net income/ Total Assets)	6.5%	20.6%	74%	11%	-2.69%	-0.95%	1.6%	1.1%
Assets ¹	1,904	2,547	5,151	6,663	5,552	512.3	2,765	9,705
Book Value Per Share ²	0.4200	0.6100	1.830	1.820	1.770	1.710	1.720	1.750
Cash Flow per Share	-	-	1.390	0.1200	-	-	-	-
Capex ¹	116	192	435	409	571	250	150	150
Capex / Sales	7.77%	9%	6.08%	15.22%	69.45%	24.25%	11.66%	10.31%
Announcement Date	30/08/19	10/08/20	26/08/21	22/08/22	29/08/23	-	-	-

¹MYR in Million²MYR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

C+

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

0.86 MYR

Average target price

0.9633 MYR

Spread / Average Target

+12.02%

	1st Jan change	Capi.
SUPERMAX CORPORATION	-8.51%	445M
COLOPLAST A/S	+11.63%	27.79B
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED	-31.67%	2.98B
WINNER MEDICAL CO., LTD.	-14.68%	2.52B
INTCO MEDICAL TECHNOLOGY CO., LTD.	+11.64%	2.34B
HARTALEGA HOLDINGS	+2.96%	1.91B
HARBIN FUERJIA TECHNOLOGY CO., LTD.	-11.65%	1.83B
TOP GLOVE CORPORATION BHD.	-1.67%	1.39B
NAKANISHI INC.	-0.38%	1.27B
KANGJI MEDICAL HOLDINGS LIMITED	+3.58%	1.13B